For patients receiving THA, preoperative anaemia is a reliable and substantial predictor of unfavourable outcomes. For patient optimization and risk stratification, systematic identification before surgery is crucial. However, unless significant randomized controlled trials demonstrate that correction results in better patient-centred outcomes, the classification of anaemia as a modifiable risk factor should be approached with caution. To improve treatment for this group, it is essential to address existing evidence gaps and implementation issues.
Z. Chen (Fri,) studied this question.